Abstract

IFNγ-producing CD4+ T cells (IFNγ+CD4+ T cells) are the key orchestrators of protective immunity against Mycobacterium tuberculosis (Mtb). Primarily, these cells act by enabling Mtb-infected macrophages to enforce phagosome-lysosome fusion, produce reactive nitrogen intermediates (RNIs), and activate autophagy pathways. However, TB is a heterogeneous disease and a host of clinical and experimental findings has also implicated IFNγ+CD4+ T cells in TB pathogenesis. High frequency of IFNγ+CD4+ T cells is the most invariable feature of the active disease. Active TB patients mount a heightened IFNγ+CD4+ T cell response to mycobacterial antigens and demonstrate an IFNγ-inducible transcriptomic signature. IFNγ+CD4+ T cells have also been shown to mediate TB-associated immune reconstitution inflammatory syndrome (TB–IRIS) observed in a subset of antiretroviral therapy (ART)-treated HIV- and Mtb-coinfected people. The pathological face of IFNγ+CD4+ T cells during mycobacterial infection is further uncovered by studies in the animal model of TB–IRIS and in Mtb-infected PD-1−/− mice. This manuscript encompasses the evidence supporting the dual role of IFNγ+CD4+ T cells during Mtb infection and sheds light on immune mechanisms involved in protection versus pathogenesis.

Highlights

  • Tuberculosis (TB) continues to be one of the major causes of morbidity and mortality worldwide [1]

  • A key role in ­CD4+ T cell-mediated macrophage activation can be attributed to IFNγ, which helps in Mycobacterium tuberculosis (Mtb) clearance by inducing inducible nitric oxide synthase (iNOS) expression and enforcing phagosomelysosome fusion [2]. ­TH1-polarized ­CD4+ T cells are the main source of IFNγ during mycobacterial infections

  • With increasing recognition of TB as a heterogeneous disease [2], IFNγ+CD4+ T cells have been implicated in TB pathogenesis

Read more

Summary

Introduction

Tuberculosis (TB) continues to be one of the major causes of morbidity and mortality worldwide [1]. Both human and animal studies have established that IFNγ+CD4+ T cells are the key mediators of protective immunity against Mtb. It has been shown that mice deficient in IFNγ are unable to control low-dose Mtb infection and succumb to the progressive disease [7,8,9]. Studies with Mtb-infected macrophages have shown that IFNγ signalling can activate these cells to enforce phagosome maturation and eliminate the intracellular bacilli [25].

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call